Jan 18, 2024 The application of G2/21 by the Court of Appeal By Adrian Chew Jonathan Ross This article is part of our Biotech Review of the Year - Issue 11 publication On 4 May 2023, the Court of Appeal, with the leading...
Jan 18, 2024 The first seven months of the Unified Patent Court By Gregory Bacon Charlie French Jonathan Ross This article is part of our Biotech Review of the Year - Issue 11 publication Following years of gestation the UPC finally opened its...
Jan 18, 2024 The Commission looks again at SPCs in the EU By Katie Cambrook Kathryn Hambly This article is part of our Biotech Review of the Year - Issue 11 publication On 27 April 2023 the Commission put forward new proposals...
Jan 18, 2024 Revision of the EU pharmaceutical law regime – what does it mean for biotech companies? By Xisca Borrás This article is part of our Biotech Review of the Year - Issue 11 publication In 2023, the European Commission (EC) proposed its most...